Relapse-independent multiple sclerosis progression under natalizumab

The objective of this study was to investigate confirmed progression independent of relapse activity in relapsing-remitting multiple sclerosis patients under long-term natalizumab treatment. We performed a retrospective, cross-sectional study of clinical data captured between 1994 and 2019 at two Ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Graf, Jonas, Leussink, Verena I, Soncin, Giulia, Lepka, Klaudia, Meinl, Ingrid, Kümpfel, Tania, Meuth, Sven G, Hartung, Hans-Peter, Havla, Joachim, Aktas, Orhan, Albrecht, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573181/
https://www.ncbi.nlm.nih.gov/pubmed/34755108
http://dx.doi.org/10.1093/braincomms/fcab229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573181/
https://www.ncbi.nlm.nih.gov/pubmed/34755108
http://dx.doi.org/10.1093/braincomms/fcab229

Ejemplares similares